vs
Clipper Realty Inc.（CLPR）与RHYTHM PHARMACEUTICALS, INC.（RYTM）财务数据对比。点击上方公司名可切换其他公司
RHYTHM PHARMACEUTICALS, INC.的季度营收约是Clipper Realty Inc.的1.6倍（$60.1M vs $37.1M），Clipper Realty Inc.净利率更高（-30.4% vs -92.6%，领先62.2%），RHYTHM PHARMACEUTICALS, INC.同比增速更快（83.8% vs -2.6%），过去两年RHYTHM PHARMACEUTICALS, INC.的营收复合增速更高（43.8% vs 1.8%）
Clipper Realty Inc.旗下Clipper Equity由大卫·比斯特里瑟和山姆·莱文森牵头成立，在美国纽约与新泽西州拥有超60栋物业，合计数千套住宅单元。该企业最为人熟知的事迹是曾在2007年2月出价13亿美元收购纽约布鲁克林的斯塔雷特城住宅区，该交易曾是当时全球规模最大的房地产交易之一。
Rhythm Pharmaceuticals是一家专注于罕见病领域的生物制药企业，主要开发和商业化针对罕见遗传性肥胖症的靶向疗法，覆盖POMC缺陷、LEPR缺陷、巴德-毕德氏综合征等适应症，服务北美、欧洲地区缺少有效治疗方案的患者群体。
CLPR vs RYTM — 直观对比
营收规模更大
RYTM
是对方的1.6倍
$37.1M
营收增速更快
RYTM
高出86.4%
-2.6%
净利率更高
CLPR
高出62.2%
-92.6%
两年增速更快
RYTM
近两年复合增速
1.8%
损益表 — Q4 FY2025 vs Q1 FY2026
| 指标 | | |
|---|---|---|
| 营收 | $37.1M | $60.1M |
| 净利润 | $-11.3M | $-55.6M |
| 毛利率 | -5.2% | 88.1% |
| 营业利润率 | 21.8% | -87.1% |
| 净利率 | -30.4% | -92.6% |
| 营收同比 | -2.6% | 83.8% |
| 净利润同比 | -938.6% | — |
| 每股收益（稀释后） | — | $-0.83 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收CLPRRYTM
| Q1 26 | — | $60.1M | ||
| Q4 25 | $37.1M | $57.3M | ||
| Q3 25 | $37.7M | $51.3M | ||
| Q2 25 | $39.0M | $48.5M | ||
| Q1 25 | $39.4M | $32.7M | ||
| Q4 24 | $38.0M | $41.8M | ||
| Q3 24 | $37.6M | $33.3M | ||
| Q2 24 | $37.3M | $29.1M |
净利润CLPRRYTM
| Q1 26 | — | $-55.6M | ||
| Q4 25 | $-11.3M | $-47.5M | ||
| Q3 25 | $-4.6M | $-52.9M | ||
| Q2 25 | $-1.4M | $-46.6M | ||
| Q1 25 | $-35.1M | $-49.5M | ||
| Q4 24 | $-1.1M | $-43.3M | ||
| Q3 24 | $-1.1M | $-43.6M | ||
| Q2 24 | $-1.7M | $-32.3M |
毛利率CLPRRYTM
| Q1 26 | — | 88.1% | ||
| Q4 25 | -5.2% | 91.6% | ||
| Q3 25 | 23.6% | 89.3% | ||
| Q2 25 | 27.8% | 88.6% | ||
| Q1 25 | -34.5% | 88.8% | ||
| Q4 24 | 28.8% | 90.9% | ||
| Q3 24 | 28.6% | 88.5% | ||
| Q2 24 | 26.8% | 89.9% |
营业利润率CLPRRYTM
| Q1 26 | — | -87.1% | ||
| Q4 25 | 21.8% | -82.2% | ||
| Q3 25 | 23.6% | -102.6% | ||
| Q2 25 | 27.7% | -93.4% | ||
| Q1 25 | -59.9% | -143.7% | ||
| Q4 24 | 28.1% | -98.6% | ||
| Q3 24 | 28.6% | -132.0% | ||
| Q2 24 | 26.8% | -139.2% |
净利率CLPRRYTM
| Q1 26 | — | -92.6% | ||
| Q4 25 | -30.4% | -83.0% | ||
| Q3 25 | -12.2% | -103.1% | ||
| Q2 25 | -3.5% | -96.1% | ||
| Q1 25 | -89.1% | -151.4% | ||
| Q4 24 | -2.9% | -103.6% | ||
| Q3 24 | -2.9% | -131.2% | ||
| Q2 24 | -4.7% | -110.9% |
每股收益（稀释后）CLPRRYTM
| Q1 26 | — | $-0.83 | ||
| Q4 25 | — | $-0.73 | ||
| Q3 25 | — | $-0.82 | ||
| Q2 25 | — | $-0.75 | ||
| Q1 25 | — | $-0.81 | ||
| Q4 24 | — | $-0.71 | ||
| Q3 24 | — | $-0.73 | ||
| Q2 24 | — | $-0.55 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $30.8M | $340.6M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $-30.7M | $122.9M |
| 总资产 | $1.2B | $442.3M |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资CLPRRYTM
| Q1 26 | — | $340.6M | ||
| Q4 25 | $30.8M | $388.9M | ||
| Q3 25 | $26.1M | $416.1M | ||
| Q2 25 | $32.0M | $291.0M | ||
| Q1 25 | $21.3M | $314.5M | ||
| Q4 24 | $19.9M | $320.6M | ||
| Q3 24 | $18.6M | $298.4M | ||
| Q2 24 | $20.3M | $319.1M |
总债务CLPRRYTM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $1.3B | — | ||
| Q4 24 | $1.3B | — | ||
| Q3 24 | $1.3B | — | ||
| Q2 24 | $1.2B | — |
股东权益CLPRRYTM
| Q1 26 | — | $122.9M | ||
| Q4 25 | $-30.7M | $139.1M | ||
| Q3 25 | $-25.0M | $148.8M | ||
| Q2 25 | $-21.9M | $-11.9M | ||
| Q1 25 | $-20.1M | $18.9M | ||
| Q4 24 | $-5.4M | $21.7M | ||
| Q3 24 | $-3.6M | $11.2M | ||
| Q2 24 | $-1.8M | $39.3M |
总资产CLPRRYTM
| Q1 26 | — | $442.3M | ||
| Q4 25 | $1.2B | $480.2M | ||
| Q3 25 | $1.2B | $506.9M | ||
| Q2 25 | $1.2B | $372.7M | ||
| Q1 25 | $1.3B | $386.7M | ||
| Q4 24 | $1.3B | $392.3M | ||
| Q3 24 | $1.3B | $363.6M | ||
| Q2 24 | $1.3B | $381.8M |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $22.6M | — |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | — | — |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流CLPRRYTM
| Q1 26 | — | — | ||
| Q4 25 | $22.6M | $-25.4M | ||
| Q3 25 | $1.4M | $-26.6M | ||
| Q2 25 | $8.4M | $-23.3M | ||
| Q1 25 | $6.7M | $-40.4M | ||
| Q4 24 | $31.9M | $-18.8M | ||
| Q3 24 | $6.3M | $-25.2M | ||
| Q2 24 | $8.8M | $-29.1M |
自由现金流CLPRRYTM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.6M | — | ||
| Q4 24 | $-37.9M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
自由现金流率CLPRRYTM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -11.7% | — | ||
| Q4 24 | -99.5% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
资本支出强度CLPRRYTM
| Q1 26 | — | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.6% | — | ||
| Q4 24 | 183.3% | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
CLPR
| Residential Segment | $30.8M | 83% |
| Commercial Real Estate | $6.2M | 17% |
RYTM
暂无分部数据
